课题基金 / 基金详情

Molecular Basis of Human Neutrophil alpha-Defensin Function

Molecular Basis of Human Neutrophil alpha-Defensin Function
人中性粒细胞α-防御素功能的分子基础
批准号:
7173729
负责人:
WUYUAN LU
金额:
$8.05万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-02-01 至 2007-06-30

项目摘要

项目成果

WUYUAN LU的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):人防御素是一个3-4 kDa、阳离子和富含cys的抗菌蛋白家族,主要在白细胞和上皮细胞中表达。它们可能通过破坏带负电荷的微生物膜来杀死多种微生物,在吞噬作用和粘膜保护中发挥关键作用,防止病原体入侵。作为先天免疫的重要组成部分,人防御素还通过吸引单核细胞、T淋巴细胞亚群和未成熟的树突状细胞,在适应性免疫中作为有效的免疫调节剂发挥作用。最近,三种人类中性粒细胞防御素(HNP1-3)在体外抑制HFV-1感染,它们在n端有一个氨基酸残基,彼此不同。我们发现,人类中性粒细胞a-防御素(HNP4)的远亲第四个成员和两个人类肠道α -防御素(HD5和HD6)也是外周血单核细胞中HIV-1复制的有效抑制剂。
英文摘要
DESCRIPTION (provided by applicant): Human (-defensins are a family of 3-4 kDa, cationic and Cys-rich antimicrobial proteins expressed predominantly in leukocytes and epithelial cells. They kill a broad range of microbes presumably through disruption of the negatively charged microbial membrane, playing critical roles in phagocytosis and in mucosal protection against invading pathogens. While an important component of innate immunity, human (-defensins also function as effective immune modulators in adaptive immunity by chemoattracting monocytes, subsets of T lymphocytes and immature dendritic cells. Recently, three human neutrophil (-defensins (HNP1-3), differing from each other by a single amino acid residue at the N-terminus have been shown to suppress HFV-1 infection in vitro. We have found that the distantly related fourth member of human neutrophil a-defensins (HNP4) and two human intestinal alpha-defensins (HD5 and HD6) are also effective inhibitors of HIV-1 replication in peripheral blood mononuclear cells. Despite the prominent roles alpha-defensins play in both innate and adaptive immunity and their potential therapeutic value in the treatment of infectious diseases, the structure/function relationships for these antimicrobial proteins have not yet been explored. The sequence rules and structural determinants that govern the great variety of biological functions of alpha-defensins and mechanisms of their action continue to remain poorly understood. Such study has been hindered, in part, by the difficulty producing recombinant defensins due to their inherent antibiotic and membranolytic properties. On the other hand, chemical synthesis of alpha-defensins, in spite of their small size, is technically challenging due to known problems associated with oxidative folding. Consequently, a significant body of the published work on alpha-defensins has been based largely on studies of HNP1-3 purified from neutrophils. As the other three native alpha-defensins have been recovered in amounts that are small (HNP4), smaller (HD5), or nil (HD6), considerably less is known about their properties. Our laboratory has recently developed a robust synthetic approach to, and an efficient folding protocol for, the production of all six human alpha-defensins in high purity and yield, enabling for the first time a systematic and comparative structure/function relationship study on these antimicrobial proteins. Such study will not only provide a better understanding of how defensins function at the molecular level, but more importantly, yield valuable insights into designing defensin-based novel therapeutic agents to combat infectious microbes. Specific aims envisioned in this application are as follows. Specific Aim 1: Elucidate the mechanism of inhibition of HNPs by their pro peptides. Specific Aim 2: Dissect the molecular determinants for the antimicrobial activity and specificity of alpha-defensins. Specific Aim 3: Decipher the physiological relevance and functional importance of HNP oligomerization.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Anticancer peptide therapeutics
Anticancer peptide therapeutics
Core B-Specimen and Reagent Core
D-peptide activators of p53 as anticancer therapeutics
海外基金